Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology

Maestú F, de Haan W, Busche MA, DeFelipe J.

Ageing Res Rev. 2021 Aug;69:101372. doi: 10.1016/j.arr.2021.101372. Epub 2021 May 21.

Longitudinal study of primary progressive aphasia in a patient with pathologically diagnosed Alzheimer's disease: a case report

Takaya M, Ishii K, Saigoh K, Shirakawa O.

J Med Case Rep. 2021 May 26;15(1):272. doi: 10.1186/s13256-021-02867-6.

Metabolic syndrome and the risk of late onset Alzheimer's disease: An updated review and meta-analysis

Zuin M, Roncon L, Passaro A, Cervellati C, Zuliani G.

Nutr Metab Cardiovasc Dis. 2021 Jul 22;31(8):2244-2252. doi: 10.1016/j.numecd.2021.03.020. Epub 2021 Apr 1.

A multicenter comparison of [(18)F]flortaucipir, [(18)F]RO948, and [(18)F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis

Leuzy A, Pascoal TA, Strandberg O, Insel P, Smith R, Mattsson-Carlgren N, Benedet AL, Cho H, Lyoo CH, La Joie R, Rabinovici GD, Ossenkoppele R, Rosa-Neto P, Hansson O.

Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2295-2305. doi: 10.1007/s00259-021-05401-4. Epub 2021 May 27.

[Role of the Aß1-42/Aß1-40 ratio in the concept 'Alzheimer's disease contributes to mild cognitive impairment']

Monge-García V, Llorca-Tolón L, Gasparini-Berenguer R, Monge-Argilés JA.

Rev Neurol. 2021 Jun 1;72(11):371-376. doi: 10.33588/rn.7211.2020594.

Factor analyses of the ADNI neuropsychological battery: An examination of diagnostic and longitudinal invariance

Chang M, Brainerd CJ.

Neuropsychology. 2021 May;35(4):434-450. doi: 10.1037/neu0000736.

Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-β transmission

Jaunmuktane Z, Banerjee G, Paine S, Parry-Jones A, Rudge P, Grieve J, Toma AK, Farmer SF, Mead S, Houlden H, Werring DJ, Brandner S.

Acta Neuropathol. 2021 Jul;142(1):211-215. doi: 10.1007/s00401-021-02326-y. Epub 2021 May 28.

Sleep, Orexin and Cognition

Toor B, Ray LB, Pozzobon A, Fogel SM.

Front Neurol Neurosci. 2021;45:38-51. doi: 10.1159/000514960. Epub 2021 May 28.

Exercise and estrogen: common pathways in Alzheimer's disease pathology

Bagit A, Hayward GC, MacPherson REK.

Am J Physiol Endocrinol Metab. 2021 Jul 1;321(1):E164-E168. doi: 10.1152/ajpendo.00008.2021. Epub 2021 May 31.

Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease

Sharma C, Kim S, Nam Y, Jung UJ, Kim SR.

Int J Mol Sci. 2021 May 3;22(9):4850. doi: 10.3390/ijms22094850.

Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease

Burillo J, Marqués P, Jiménez B, González-Blanco C, Benito M, Guillén C.

Cells. 2021 May 18;10(5):1236. doi: 10.3390/cells10051236.

Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer's disease

Rompicherla SKL, Arumugam K, Bojja SL, Kumar N, Rao CM.

Naunyn Schmiedebergs Arch Pharmacol. 2021 Aug;394(8):1737-1755. doi: 10.1007/s00210-021-02096-0. Epub 2021 Jun 4.

Illuminating Neural Circuits in Alzheimer's Disease

Ying Y, Wang JZ.

Neurosci Bull. 2021 Aug;37(8):1203-1217. doi: 10.1007/s12264-021-00716-6. Epub 2021 Jun 5.

Partial volume correction in arterial spin labeling perfusion MRI: A method to disentangle anatomy from physiology or an analysis step too far?

Chappell MA, McConnell FAK, Golay X, Günther M, Hernandez-Tamames JA, van Osch MJ, Asllani I.

Neuroimage. 2021 Sep;238:118236. doi: 10.1016/j.neuroimage.2021.118236. Epub 2021 Jun 4.

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I, Montrreal L, Antúnez C, Antonell A, Tankard RM, Bis JC, Sims R, Bellenguez C, Quintela I, González-Perez A, Calero M, Franco-Macías E, Macías J, Blesa R, Cervera-Carles L, Menéndez-González M, Frank-García A, Royo JL, Moreno F, Huerto Vilas R, Baquero M, Diez-Fairen M, Lage C, García-Madrona S, García-González P, Alarcón-Martín E, Valero S, Sotolongo-Grau O, Ullgren A, Naj AC, Lemstra AW, Benaque A, Pérez-Cordón A, Benussi A, Rábano A, Padovani A, Squassina A, de Mendonça A, Arias Pastor A, Kok AAL, Meggy A, Pastor AB, Espinosa A, Corma-Gómez A, Martín Montes A, Sanabria Á, DeStefano AL, Schneider A, Haapasalo A, Kinhult Ståhlbom A, Tybjærg-Hansen A, Hartmann AM, Spottke A, Corbatón-Anchuelo A, Rongve A, Borroni B, Arosio B, Nacmias B, Nordestgaard BG, Kunkle BW, Charbonnier C, Abdelnour C, Masullo C, Martínez Rodríguez C, Muñoz-Fernandez C, Dufouil C, Graff C, Ferreira CB, Chillotti C, Reynolds CA, Fenoglio C, Van Broeckhoven C, Clark C, Pisanu C, Satizabal CL, Holmes C, Buiza-Rueda D, Aarsland D, Rujescu D, Alcolea D, Galimberti D, Wallon D, Seripa D, Grünblatt E, Dardiotis E, Düzel E, Scarpini E, Conti E, Rubino E, Gelpi E, Rodriguez-Rodriguez E, et al.

Nat Commun. 2021 Jun 7;12(1):3417. doi: 10.1038/s41467-021-22491-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias